Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis
Completed · Phase 1
Conditions studied: Lupus Erythematosus, Lupus Nephritis
In brief
This is a multi-center study to evaluate the safety, tolerability, PK, PD, and clinical activity of itolizumab (EQ001) in subjects with Systemic Lupus Erythematosus with or without Active Proliferative Lupus Nephritis
Key facts
- Study ID
- NCT04128579
- Run by
- Biocon Limited
- People needed
- 52
- Starts
- 2019-10-01
- Expected to finish
- 2024-01-18
- Last updated by the study team
- 2026-06-04
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- AKDHC Medical Research Services, LLC — Sun City, Arizona, United States
- California Institute of Renal Research — Chula Vista, California, United States
- University of California San Diego Perlman Ambulatory Clinic — La Jolla, California, United States
- Clinical Research of West Florida - Clearwater — Clearwater, Florida, United States
- Centre for Rheumatology, Immunology and Arthritis — Fort Lauderdale, Florida, United States
- University of Florida, Division of Rheumatology — Gainesville, Florida, United States
- Clinical Site Partners Leesburg, LLC — Leesburg, Florida, United States
- SouthCoast Research Center Inc — Miami, Florida, United States
- Hope Clinical Trials — Miami, Florida, United States
- Omega Research Maitland, LLC — Orlando, Florida, United States
- Clinical Research of West Florida - Tampa — Tampa, Florida, United States
- University of South Florida — Tampa, Florida, United States
- Georgia Nephrology — Lawrenceville, Georgia, United States
- Northwell Health / Division of Rheumatology — Great Neck, New York, United States
- Columbia University Medical Center, Div of Nephrology — New York, New York, United States
- Albert Einstein College of Medicine, Montefiore Medical Center — The Bronx, New York, United States
- Northeast Clinical Research Center, LLC — Bethlehem, Pennsylvania, United States
- Dallas Renal Group — Dallas, Texas, United States
- Prolato Clinical Research Center (PCRC) — Houston, Texas, United States
- Post Graduate Institute of Medical Education and Research (PGIMER) — Chandigarh, India
- Medanta - The Medicity Hospital — Gurugramam, India
- MAX Super Specialty Hospital — New Delhi, India
- Jawaharlal Nehru Institute of Postgraduate Medical Education and Research (JIPMER) — Puducherry, India
- SP ZOZ Centralny Szpital Kliniczny Uniwersytetu Medycznego w Lodzi, Klinika Nefrologii, Hipertensjologii — Lodz, Poland
- Miedzyleski Szpital Specjalistyczny w Warszawie, Oddzial Nefrologiczny i Stacja Dializ — Warsaw, Poland
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.